ZW49
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ZW49, covering 2025-01-29 to 2025-01-29. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers [Phase 1]